Preferred Label : Lymphoproliferative syndrome 1;
Symbol : LPFS1;
CISMeF acronym : LPFS1;
Type : Phenotype, molecular basis known;
Description : Lymphoproliferative syndrome-1 is an autosomal recessive primary immunodeficiency
characterized by onset in early childhood of Epstein-Barr virus (EBV)-associated immune
dysregulation, manifest as lymphoma, lymphomatoid granulomatosis, hemophagocytic lymphohistiocytosis,
Hodgkin disease, and/or hypogammaglobulinemia. Autoimmune disorders, such as autoimmune
hemolytic anemia or renal disease, may also occur. Patients show a high EBV viral
load and decreased invariant natural killer T cells. It is unknown whether patients
with ITK mutations are intrinsically susceptible to development of lymphoma or dysgammaglobulinemia
in the absence of EBV infection (summary by Stepensky et al., 2011; Linka et al.,
2012). For a discussion of genetic heterogeneity of lymphoproliferative syndrome,
see XLP1 (308240).;
Inheritance : Autosomal recessive;
Molecular basis : Caused by mutation in the IL2-inducible T-cell kinase gene (ITK, 186973.0001);
Neoplasia : Increased risk for lymphoma Hodgkin disease;
Laboratory abnormalities : Elevated erythrocyte sedimentation rate (ESR); Increased C-reactive protein; High EBV viral load;
Prefixed ID : #613011;
Origin ID : 613011;
UMLS CUI : C3552634;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
Not associated HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)